IrelandHSE Funds Skyclarys for Friedreich's Ataxia Patients in Ireland
The HSE has decided to fund Skyclarys, a drug for Friedreich's ataxia, a move welcomed by campaigners who expect it to improve patients' quality of life.
Quorum · collective opinions
HSE Funds Skyclarys for Friedreich's Ataxia Patients
First report 23h agoLast update 23h ago1 takes▲ 1
support drug fundingpositiveShow 1 post
started 23h ago•Last update 23h ago
Campaigners and patients express delight and relief over the HSE's decision to fund Skyclarys, a drug for Friedreich's ataxia, which will improve quality of life.
iWitness comments
No comments yet — be the first to weigh in.